Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participants having the following signs and symptoms of disease: Itching, History of Asthma / hay fever in 1st degree relatives, Visible flexural eczema, Excoriation, Burning sensation, Lichenification, Crusting, Dry skin. 2. Participants who are able and willing to comply with the protocol and to sign ICF 3. Chronicity of more than 6 months and less than 2 years
Exclusion criteria
Exclusion criteria: 1.Participants aged Less than 18 years and more than 65 years 2. Known cases of significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction, Malignancy, HIV infection, AIDS, etc. 3. Any other clinical condition that in the opinion of the investigator would compromise the patientâ??s safety or successful participation in the trial. 4. Pregnancy and Lactation 5. Known allergy, sensitivity or intolerance to the study drug or any of its ingredients 6. Participants with active alcohol intake and/or drug abuse 7. Participants not willing to sign the ICF and to attend treatment schedule regularly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 25% change in appearance and symptomatic relief will be considered significantTimepoint: 42 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Digital photography of all lesions will be done using conditions (fixed room, fixed lighting and fixed camera settings )Timepoint: 42 days | — |
Countries
India
Contacts
National Research Institute of Unani Medicine For Skin Disorders